Skip to main content

Oral idelalisib elicits response in half of refractory CLL patients

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Oral idelalisib elicits response in half of refractory CLL patients

User login

Username

Password

Reset your password

Type	Lead	score